| Dr Robert Dave Feinstein, MD | |
|
400 Fairview Heights Rd, Suite 202, Summersville, WV 26651-9308 | |
| (304) 872-8411 | |
| (304) 872-0442 |
| Full Name | Dr Robert Dave Feinstein |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 400 Fairview Heights Rd, Summersville, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851489496 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | ME 74517 (Florida) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 26147 (West Virginia) | Primary |
| Entity Name | Integrated Health Care Providers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225057185 PECOS PAC ID: 6204733520 Enrollment ID: O20031216000069 |
News Archive
The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer.
Inhaled glucocorticoids for the treatment of asthma during pregnancy are not associated with an increased risk of most diseases in offspring, but may be a risk factor for endocrine and metabolic disturbances, according to a new study.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Dave Feinstein, MD Po Box 1320, Saint Albans, WV 25177-1320 Ph: (304) 388-1724 | Dr Robert Dave Feinstein, MD 400 Fairview Heights Rd, Suite 202, Summersville, WV 26651-9308 Ph: (304) 872-8411 |
News Archive
The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer.
Inhaled glucocorticoids for the treatment of asthma during pregnancy are not associated with an increased risk of most diseases in offspring, but may be a risk factor for endocrine and metabolic disturbances, according to a new study.
New York City officials on Wednesday said that people living in government-subsidized housing for HIV-positive people will be charged more for rent after the state required that changes be made to the payment formula effective Nov. 1, the New York Times reports.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.
› Verified 7 days ago
Amit Kaushal, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-872-8601 | |
Dr. Paul Joseph Conley, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-872-5124 Fax: 304-872-0675 | |
Dr. Marvin Jerome Wurth, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Fairview Heights Rd, Summersville, WV 26651 Phone: 304-872-5124 Fax: 304-872-0675 |